Report of severe neurotoxicity with cyclophosphamide.
Nagarajan
R
R
Peters
C
C
Orchard
P
P
Rydholm
N
N
D000961:Antilymphocyte Serum / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D002066:Busulfan / Q000627:therapeutic use; D002648:Child; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects*; D004334:Drug Administration Schedule; D005199:Fanconi Anemia / Q000175:diagnosis / Q000628:therapy*; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects / Q000379:methods; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D008140:Lorazepam / Q000627:therapeutic use; D008297:Male; D012640:Seizures / Q000139:chemically induced* / Q000188:drug therapy; D014916:Whole-Body Irradiation
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D002066:Busulfan; D008140:Lorazepam